Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
Kidney International|October 28, 2022
A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipientsAurélie Moreau, Delphine Kervella, Laurence Bouchet-Delbos, et al.
Kidney International|February 21, 2018
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indicesIngeborg M Bajema, Suzanne Wilhelmus, Charles E Alpers, et al.
Virchows Archiv : an International Journal of Pathology|August 17, 2024
What factors influence cellular pathologists' confidence in case reporting?Harriet Evans, Peter K Kimani, Louise Hiller, et al.
Ebiomedicine|July 14, 2026
Individualised treatment effects of corticosteroids in IgA nephropathyDavid L Hölscher, Nikolas E J Schmitz, Leon Niggemeier, et al.
Nephron|November 21, 2015
Tonsillectomy in a European Cohort of 1,147 Patients with IgA NephropathyJohn Feehally, Rosanna Coppo, Stéphan Troyanov, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2020
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipientsPaul N Harden, David S Game, Birgit Sawitzki, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Digital Pathology Transformation in a Supraregional Germ Cell Tumour NetworkRichard Colling, Andrew Protheroe, Mark Sullivan, et al.
Plos One|March 9, 2023
Contactin-1 links autoimmune neuropathy and membranous glomerulonephritisJanev Fehmi, Alexander J Davies, Marilina Antonelou, et al.
Kidney International|April 4, 2014
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatmentsRosanna Coppo, Stéphan Troyanov, Shubha Bellur, et al.
Kidney International Reports|December 18, 2023
Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA NephropathyFrederick W K Tam, James Tumlin, Jonathan Barratt, et al.
Pageof 19